• Markets
  • icon
  • Companies
GSS · ASX

Genetic Signatures Ltd. (ASX:GSS)

AU$0.75

 -0.01 (-1.316%)
ASX:Live
26/07/2024 02:33:54 PM
HALO Price Momentum HALO Ords HALO Momentum GROWTH AUS All-Consensus +1
Consensus Score
/10
Recommend
Target Price
Deviation
Unlock Full Consensus Insights

GSS Overview

GSS Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Very Weak

Earnings

Weak

Growth

Earnings

Neutral

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Strong

About GSS

Telephone

Address

Description

Genetic Signatures Ltd. is a research company, which engages in the identification and commercialization of individual genetic signatures for the diagnosis of infectious diseases. It is also involved in the sale of associated products into the diagnostic and research marketplaces. Its products include the treatment for gastrointestinal infections, respiratory, sexual health, anti-microbial resistance, meningitis, and tropical disease. It operates in the following geographical segments: Asia Pacific, Europe, Middle East, and Africa (EMEA), and Americas. The company was founded by Robert J. Birrell, Christopher M. Abbott, and Geoffrey Grigg on February 15, 2001 and is headquartered in Newtown, Australia.

GSS Price Chart

Key Stats

Market Cap

AU$174.46M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.38 - 0.85

Trade Value (12mth)

AU$19,089.00

1 week

-1.3%

1 month

7.04%

YTD

87.65%

1 year

18.79%

All time high

2.87

Key Fundamentals

EPS 3 yr Growth

483.500%

EBITDA Margin

-102.50%

Operating Cashflow

-$12m

Free Cash Flow Return

-25.50%

ROIC

-28.80%

Interest Coverage

-17,365.00

Quick Ratio

4.50

Other Data

Shares on Issue (Fully Dilluted)

144m

HALO Sector

Next Company Report Date

28-Aug-24

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

GSS Announcements

Latest Announcements

Date Announcements

09 July 24

Change in substantial holding

×

Change in substantial holding

08 July 24

Application for quotation of securities - GSS

×

Application for quotation of securities - GSS

08 July 24

Change of Director's Interest Notice - T Radford

×

Change of Director's Interest Notice - T Radford

08 July 24

Change of Director's Interest Notice - S Chatonsky

×

Change of Director's Interest Notice - S Chatonsky

08 July 24

Change of Director's Interest Notice - C Waldron

×

Change of Director's Interest Notice - C Waldron

05 July 24

Change of Director's Interest Notice

×

Change of Director's Interest Notice

04 July 24

Completion of Underwritten Retail Entitlement Offer

×

Completion of Underwritten Retail Entitlement Offer

28 June 24

Notification of cessation of securities - GSS

×

Notification of cessation of securities - GSS

26 June 24

Change of Director's Interest Notice

×

Change of Director's Interest Notice

17 June 24

Change in substantial holding

×

Change in substantial holding

17 June 24

Becoming a substantial holder

×

Becoming a substantial holder

17 June 24

Change in substantial holding

×

Change in substantial holding

13 June 24

Application for quotation of securities - GSS

×

Application for quotation of securities - GSS

13 June 24

Cleansing Notice

×

Cleansing Notice

12 June 24

Despatch Of Retail Entitlement Offer Booklet

×

Despatch Of Retail Entitlement Offer Booklet

12 June 24

Letter To Eligible Retail Shareholders

×

Letter To Eligible Retail Shareholders

12 June 24

Letter To Ineligible Shareholders

×

Letter To Ineligible Shareholders

06 June 24

Completion of Institutional Entitlement Offer and Placement

×

Completion of Institutional Entitlement Offer and Placement

04 June 24

FDA Clearance For Gastrointestinal Parasite Detection Kit

×

FDA Clearance For Gastrointestinal Parasite Detection Kit

04 June 24

Genetic Signatures Appoints Allison Rossiter As CEO

×

Genetic Signatures Appoints Allison Rossiter As CEO

04 June 24

Genetic Signatures Announces $30 Million Capital Raising

×

Genetic Signatures Announces $30 Million Capital Raising

04 June 24

FDA Clearance and Capital Raising Presentation

×

FDA Clearance and Capital Raising Presentation

04 June 24

Entitlement Offer Cleansing Notice

×

Entitlement Offer Cleansing Notice

04 June 24

Proposed issue of securities - GSS

×

Proposed issue of securities - GSS

04 June 24

Proposed issue of securities - GSS

×

Proposed issue of securities - GSS

GSS Fundamentals

Per Share Records

Historical data

Forecast data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock 0.01 0.02 -0.10 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock 0.01 0.02 -0.10 Lock Lock Lock
     Growth % Lock Lock Lock Lock 175.0 74.0 -547.2 Lock Lock Lock
     PE X Lock Lock Lock Lock 149.0 44.3 N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock 70.4 0.0 N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock 0.04 0.04 -0.07 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.00 0.06 -0.10 Lock Lock Lock
     Growth % Lock Lock Lock Lock 651.8 4.8 -263.7 Lock Lock Lock
     Yield % Lock Lock Lock Lock -0.3 4.8 -19.1 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock 0.0 0.0 N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.35 0.38 0.29 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.34 0.37 0.25 Lock Lock Lock
     Growth % Lock Lock Lock Lock 6.4 8.2 -31.2 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 146 145 147 Lock Lock Lock
Basic m Lock Lock Lock Lock 143 143 147 Lock Lock Lock

Financial Records

Historical data

Forecast data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales $m Lock Lock Lock Lock 28 35 17 Lock Lock Lock
     Growth % Lock Lock Lock Lock 151.1 25.2 -52.2 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 3 4 6 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 4 7 -13 Lock Lock Lock
     Growth % Lock Lock Lock Lock 280.5 68.9 -276.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock 15.1 20.4 -75.2 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 85 80 175 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock 3 5 -17 Lock Lock Lock
     Growth % Lock Lock Lock Lock 175.6 53.7 -478.9 Lock Lock Lock
     Margin % Lock Lock Lock Lock 10.5 12.9 -102.5 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 1 2 2 Lock Lock Lock
EBIT $m Lock Lock Lock Lock 2 3 -19 Lock Lock Lock
     Growth % Lock Lock Lock Lock 132.2 90.6 -736.7 Lock Lock Lock
     Margin % Lock Lock Lock Lock 5.5 8.4 -111.5 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock 2 3 -18 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock 0 0 -4 Lock Lock Lock
Net Income $m Lock Lock Lock Lock 2 3 -14 Lock Lock Lock
     Growth % Lock Lock Lock Lock 184.2 74.4 -558.8 Lock Lock Lock
     Margin % Lock Lock Lock Lock 6.2 8.6 -83.0 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock 4 10 -12 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 5 3 8 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock -5 -3 -8 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock 0 8 -14 Lock Lock Lock
     Growth % Lock Lock Lock Lock 96.1 1,866.8 -277.7 Lock Lock Lock
     Margin % Lock Lock Lock Lock -0.0 0.2 -0.8 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 30 37 16 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 54 60 49 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -30 -37 -16 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 5 5 6 Lock Lock Lock
Equity $m Lock Lock Lock Lock 49 55 43 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 49 55 43 Lock Lock Lock
     Growth % Lock Lock Lock Lock 6.6 10.9 -21.7 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock 3.2 5.1 -28.6 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock 3.6 5.6 -32.7 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock 3.2 5.7 -38.7 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock 3.7 5.9 -28.8 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock 8.8 18.8 -25.5 Lock Lock Lock

Ratios Records

Historical data

Forecast data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock 82.8 241.2 -17,365.0 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock -10.0 -8.0 0.9 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -60.2 -67.3 -38.1 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 10.3 10.7 6.0 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 7.7 8.5 4.5 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 63.2 72.0 45.0 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock 90.7 204.1 -205.2 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 4.3 7.5 2.2 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 2.5 2.5 3.1 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.7 0.8 0.6 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 9.7 9.6 22.3 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.5 0.6 0.3 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.5 0.6 0.3 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock 6.2 8.6 -109.1 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock 3.2 5.1 -37.6 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock 3.2 5.1 -28.6 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.1 1.1 1.1 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock 3.6 5.6 -32.7 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock 3.6 5.6 -32.7 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 147.3 144.5 116.6 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 84.8 49.0 165.9 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 232.2 193.5 282.4 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 28.6 42.9 46.5 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 203.5 150.6 236.0 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

N/A

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

GSS Shortsell

Frequently Asked Questions

The current share price of Genetic Signatures Ltd. (GSS:ASX) is AU$0.75.
The 52-week high share price for Genetic Signatures Ltd. (GSS:ASX) is AU$0.85.
The 52-week low share price for Genetic Signatures Ltd. (GSS:ASX)? is AU$0.38.
Genetic Signatures Ltd. (GSS:ASX) does not pay a dividend.
Genetic Signatures Ltd. (GSS:ASX) does not pay a dividend.
Genetic Signatures Ltd. (GSS:ASX) has a franking level of 0.0%.
Genetic Signatures Ltd. (GSS:ASX) is classified in the Industrials.
The current P/E ratio for Genetic Signatures Ltd. (GSS:ASX) is .